top of page

Natural Health Product Label Claims: What They Mean, What They Miss, and What Canadian Regulations Require

Updated: May 12

The natural health products (NHP) industry has expanded rapidly in recent years, driven by growing public demand for wellness and preventive healthcare solutions. Alongside this growth, however, health claims that stretch beyond what available evidence can support have become increasingly common. Phrases such as "boosts immunity" or "enhances vitality" appear routinely on product labels, occupying an uncomfortable space between legitimate benefit and promotional exaggeration. For consumers, this creates uncertainty about which products can genuinely support their health. For industry professionals, it raises questions of credibility, regulatory risk, and long-term consumer trust. Understanding how unsubstantiated claims arise, why they persist, and what can be done to address them is valuable for anyone navigating this space, whether purchasing, selling, or regulating natural health products.

 

How Unsubstantiated Natural Health Product Label Claims Develop

One of the primary sources of unsubstantiated or overstated health claims is the misinterpretation or overreach of scientific findings. Preliminary research conducted in laboratory settings or on animal models may reveal interesting biological effects, but these results are sometimes communicated to consumers as though they represent confirmed outcomes in humans. This leap from early-stage research to product marketing often overlooks the important gap between promising preliminary findings and scientifically proven clinical benefits.

A related issue involves the reliance on traditional or historical use as a substitute for rigorous clinical validation. While the long-standing use of botanical ingredients carries cultural significance, it does not satisfy the standards required by modern evidence-based medicine. Compounding this further, language choices on product labels, such as "supports" or "promotes," can be deliberately imprecise. These terms carry an implied health benefit without requiring manufacturers to meet a defined threshold. In addition, selective presentation of data and the strategic use of scientific or technical terminology can manufacture an impression of credibility even when the underlying evidence is thin.

 


Why Misleading Claims Persist

Several converging pressures have allowed overstated claims to remain commonplace within the NHP sector. Intense market competition pushes companies to construct compelling product narratives, and health claims serve as a powerful differentiator. Conducting clinical trials, however, is both costly and time-consuming, which leads some manufacturers to depend on preliminary or surrogate data as justification for their claims.

Regulatory frameworks add another layer of complexity. Although guidelines in most jurisdictions require that claims be substantiated, they frequently permit flexibility in how that substantiation is framed and presented, creating room for interpretation that some companies exploit. Beyond commercial incentives, consumer behaviour also plays a role. Tiller and co-workers highlighted that simplified health messaging spreads more readily than nuanced scientific explanations, particularly across digital and social media platforms where engagement often outweigh accuracy. Varying levels of health literacy among the public imply that bold, straightforward claims tend to resonate far more than cautiously worded ones.

 

The Real-World Safety Risks

Although unsubstantiated health claims might appear to be a matter of promotional ethics, their consequences extend into genuine public health territory. When consumers believe a product will deliver a specific health outcome, they may reduce their reliance on clinically validated treatments or delay seeking professional medical advice. This substitution effect can carry serious risks, particularly for individuals managing chronic or serious health conditions.

Product quality issues further complicate the picture. Studies have found that some NHPs contain lower concentrations of active ingredients than the amounts shown to be effective in supporting research, meaning that consumers may not receive the intended benefit even when used as directed. There is also a broader perception that natural products are inherently safe, which can encourage overconsumption or misuse without fully considering potential risks.

 

 A Practical Guide for Consumers

Before introducing a new supplement into a health routine, it is advisable to speak with a qualified healthcare professional who can offer personalized, evidence-based guidance. This is especially important for individuals managing chronic health conditions, taking prescription medications, or considering multiple supplements at the same time. It is important to recognize that natural health products can interact with other medications, affect underlying medical conditions, or cause unwanted side effects when used improperly. A qualified practitioner can help identify an appropriate supplement, recommend a suitable dosage, and evaluate the scientific evidence supporting its intended use.

Consumers should also understand that terms such as “supports,” “promotes,” or “boosts” do not always indicate clinically proven outcomes. Developing a habit of seeking reliable information from healthcare professionals, regulatory agencies, and peer-reviewed sources can go a long way in promoting safer and more effective use of natural health products.

 

What the Industry and Regulators Must Do

Meaningful reform in this area will require action on multiple fronts. At the industry level, manufacturers need to ensure that the claims made on their products accurately reflect the strength and scope of the supporting evidence, including appropriate dosing and proper ingredient characterization. Continued investment in clinical research is equally important, as it remains one of the most reliable ways to build a credible and scientifically defensible evidence base for natural health products.

Regulators can further strengthen the system by developing standards for evaluating evidence used to support health claims. Consistent enforcement would also help close some of the interpretive gaps that currently allow questionable or borderline claims to persist. Scientists and healthcare professionals have a role to play here too, speaking up against misinformation and making sure the public gets an honest picture of what the research shows.

The long-term credibility of the natural health products industry rests not on how persuasively its products are marketed, but on how honestly their benefits are represented. In a sector where consumer trust is foundational, that credibility must be built on evidence that is scientifically rigorous, transparently communicated, and genuinely substantiated.

 

 


References

1. Upton, R., David, B., Gafner, S., & Glasl, S. (2020). Botanical ingredient identification and quality assessment: strengths and limitations of analytical techniques. Phytochemistry Reviews19(5), 1157-1177.

2. U.S. Food and Drug Administration (FDA) (2005). Dietary Supplement Labeling Guide.

3. Health Canada (2006). Evidence for Safety and Efficacy of Finished Natural Health Products

4. EFSA NDA Panel (EFSA Panel on Nutrition, Novel Foods and Food Allergens), 2021. General scientific guidance for stakeholders on health claim applications (Revision 1). EFSA Journal 19(3):6553

5. Bent, S. (2008). Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. Journal of general internal medicine23(6), 854-859.

6. Cohen, P. A. (2016). The supplement paradox: negligible benefits, robust consumption. Jama316(14), 1453-1454.

7. Tiller, N. B., Sullivan, J. P., & Ekkekakis, P. (2023). Baseless claims and pseudoscience in health and wellness: a call to action for the sports, exercise, and nutrition-science community. Sports Medicine53(1), 1-5.


 


Comments


bottom of page